ABOS — Acumen Pharmaceuticals Inc

Ownership history in Integrated Wealth Concepts LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Integrated Wealth Concepts LLC reported a position in Acumen Pharmaceuticals Inc (ABOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,179 -247 -2.4% 0.00% $17K $1.71
2025 Q2 REDUCED 10,426 -4,793 -31.5% 0.00% $12K $1.16
2025 Q1 ADDED 15,219 +5,119 +50.7% 0.00% $17K $1.10
2024 Q4 UNCHANGED 10,100 — 0% 0.00% $17K $1.72
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ABOS price (monthly, adj. close)

Other funds also holding ABOS

As of 2025 Q4 — sorted by position size

Sands Capital Alternatives, LLC 3Y 1.39% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.32% Knollwood Investment Advisory, LLC 0.32% ADAR1 Capital Management, LLC 0.14% Laurion Capital Management LP 3Y 7Y 0.06% Ikarian Capital, LLC 3Y 0.04% Intrepid Financial Planning Group LLC 3Y 0.02% CATALYST FINANCIAL PARTNERS LLC 3Y 0.02% Catalyst Funds Management Pty Ltd 0.01% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01%
← Back to Integrated Wealth Concepts LLC Holdings